WHO ICTRP trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study to…
EUCTR2010-019558-42-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-019558-42-BE |
|---|---|
| Public title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety, and Tolerability of Baminercept in Subjects With Moderate to Severe Ulcerative Colitis |
| Scientific title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety, and Tolerability of Baminercept in Subjects With Moderate to Severe Ulcerative Colitis |
| Primary sponsor | Biogen Idec Ltd. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Hungary;Czech Republic;Belgium |
| Conditions | Ulcerative Colitis MedDRA version: 12.1 Level: LLT Classification code 10045365 Term: Ulcerative colitis |
| Interventions | Product Name: Baminercept Product Code: BG9924 Pharmaceutical Form: Solution for injection INN or Proposed INN: N/A CAS Number: N/A Current Sponsor code: BG9924 Other descriptive name: Baminercept Concentration unit: mg milligram(s)… |
| Registration date | Oct 13, 2010 |
| Target size | 100 |
| Secondary IDs | 104UC201 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: